Mesothelioma Treatment
Mesothelioma Cancer
- Causes of Mesothelioma
- Mesothelioma Symptoms
- Mesothelioma Diagnosis
- Mesothelioma Stages
- Mesothelioma Treatment
- Innovative Mesothelioma Treatments
- Managing Mesothelioma Pain
- Nutrition Information for Mesothelioma Patients
- Specialized Mesothelioma Care
- Mesothelioma Risks
- Mesothelioma Support Groups
- Find a Mesothelioma Attorney
- Mesothelioma News
Mesothelioma Directory
Vaccine Therapy and Ganciclovir in Treating Patients With Mesothelioma
Get Help Today
Looking for help or additional information? Contact us today.| Conditions: | Malignant Mesothelioma |
| Start Date: | August 1, 1997 |
| Phase: | Phase I |
| Status: | Active, not recruiting |
| NCT ID: | NCT00006216 |
| Study Type: | Interventional |
| Intervention: | Biological: PA-1-STK ovarian carcinoma vaccine/Drug: ganciclovir |
| Study Design: | Treatment |
| Results: | No Results Available |
| Sponsors: | Stanley S. Scott Cancer Center at Louisiana State University Medical Center - New Orleans |
| Ages: | Child/Adult/Senior |
| Enrollment: | 0 |
| Funded By: | UNKNOWN |
| First Received: | September 11, 2000 |
| End Date: | January 1, 1900 |
| Last Updated: | February 6, 2009 |
| Last Verified: | July 1, 2001 |